Dutch Bros Raises 2026 Guidance but Margin Concerns Persist

What happened

Dutch Bros raised its 2026 guidance, with revenue now expected at $2.10–$2.13B, adjusted EBITDA at $385–$390M, and capex at $350–$370M, while reaffirming a long-term target of 2,029 shops by 2029. This represents a notable increase from prior guidance of $2.05–$2.08B revenue and $370–$380M EBITDA, signaling management's confidence in sustained growth and profitability. However, the earlier DeepValue master report highlighted persistent margin pressures, including a 190 bps YoY drop in shop gross margin to 20.0% in Q1'26, driven by higher coffee and food costs and occupancy deleverage from build-to-suit leases. The new article acknowledges near-term macro and competitive pressures that may slow comparable sales and margin expansion, but argues that the stock's valuation has become more compelling after a price decline. The raised guidance is a positive data point, but it does not directly resolve the structural questions about unit economics and margin stabilization that previously warranted a WAIT rating.

Implication

The increased revenue, EBITDA, and capex guidance suggests management expects stronger growth and profitability for 2026, which could support the stock if execution matches the plan. However, the higher capex guidance indicates accelerated investment, which may extend the period of elevated occupancy and pre-opening costs, potentially delaying margin recovery. The article's bull case relies on long-term expansion and innovation, but the master report's concerns about build-to-suit leases and food program cost dilution remain unresolved and should be monitored in upcoming quarterly filings. If the stock has fallen below the prior base-case implied value of $55, the risk/reward may have improved, but the absence of margin stabilization could still lead to further downside if cost pressures persist. A more constructive stance would require evidence that occupancy/other cost deleverage moderates below +100 bps YoY and beverage/food/packaging costs stabilize, as outlined in the master report's checkpoints.

Thesis delta

The raised 2026 guidance modestly improves the fundamental outlook by lifting expected revenue and EBITDA, and the lower stock price (implied by the article) improves the valuation entry point relative to the prior WAIT assessment. However, the core thesis risk—margin compression from build-to-suit occupancy and food program costs—remains unchanged, and the increased capex guidance could prolong that pressure. Therefore, the thesis shifts from a clear WAIT to a more balanced view where the improved valuation may justify a smaller position or closer monitoring, but conviction to turn bullish is still insufficient.